EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Clinical Validation of α‐Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study

Antonia Gurgone, Vita Cardinale, Marta M Tangari, Serena Budicin, Debora Comai, Claudia Ledda, Leonardo Lopiano, Giovanni Camussi, Maurizio Zibetti, Maurizio Giustetto iD

European Journal of Neurology · 2026-02 · 33 (2)

DOI: 10.1111/ene.70508 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Neurology, online erschienen am 28.01.2026. Verfasst von Antonia Gurgone und 9 weiteren Autor:innen. Beteiligte Einrichtung: "Rita Levi-Montalcini" Department of Neuroscience, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Extracellular Vesicles, Saliva. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Torino, University of Pennsylvania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the accumulation of misfolded alpha‐synuclein (α‐Syn) and the subsequent loss of dopaminergic neurons. Identifying reliable and non‐invasive biomarkers is crucial for accelerating early diagnosis and monitoring disease progression. To this aim, we longitudinally investigated α‐Syn in salivary extracellular vesicles (SEVs) in PD patients and the correlation with clinical outcomes.

Methods

SEVs were isolated from PD patients and healthy controls (HCs) saliva using differential ultracentrifugation followed by morphological and molecular characterization. The levels of both total (α‐Syn Tot ) and oligomeric (α‐Syn Olig ) α‐Syn were quantified by ELISA.

Results

We found a significant increase in both α‐Syn Tot and α‐Syn Olig in PD‐derived SEVs compared to HCs, and receiver operating characteristic analysis revealed that α‐Syn Olig displayed higher sensitivity (65%) for discriminating PD from HCs compared to α‐Syn Tot (59%). Moreover, α‐Syn Olig levels correlated negatively with Mini‐Mental State Examination scores and were higher in patients with motor fluctuations. Finally, we found that α‐Syn Olig levels did not change after one‐year follow‐up in patients when also the clinical parameters remained unaltered.

Conclusions

These results establish for the first time that SEVs‐associated α‐Syn Olig is a promising, sensitive and non‐invasive biomarker for PD diagnosis and clinical correlation studies, bearing higher sensitivity than α‐Syn Tot . Moreover, α‐Syn Olig levels closely followed the clinical outcomes in PD patients. Finally, these findings strengthen the rationale for the further exploration of SEVs to disclose still unavailable accessible biomarkers for multiple neurological diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseExtracellular VesiclesSalivaHumansFemaleMaleBiomarkersLongitudinal StudiesAgedMiddle Aged

Stichwörter der Autor:innen

ELISA assayParkinsonextracellular vesiclesone year follow‐up studysalivary biomarkers

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • "Rita Levi-Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
  • SC Neurologia 2U, AOU Città Della Salute e Della Scienza, Turin, Italy.
  • Department of Medical Sciences, University of Turin, Turin, Italy.

ORCID-Profile: Maurizio Giustetto

Förderung

  • Università degli Studi di Torino
  • University of Pennsylvania

Zitieren

APA

Gurgone, A., Cardinale, V., Tangari, M. M., Budicin, S., Comai, D., Ledda, C., Lopiano, L., Camussi, G., Zibetti, M., & Giustetto, M. (2026). Clinical Validation of α‐Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study. European Journal of Neurology, 33(2). https://doi.org/10.1111/ene.70508

Vancouver

Gurgone A, Cardinale V, Tangari MM, Budicin S, Comai D, Ledda C, et al. Clinical Validation of α‐Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study. European Journal of Neurology. 2026;33(2). doi:10.1111/ene.70508

BibTeX
@article{Gurgone2026,
  author = {Gurgone, Antonia and Cardinale, Vita and Tangari, Marta M and Budicin, Serena and Comai, Debora and Ledda, Claudia and Lopiano, Leonardo and Camussi, Giovanni and Zibetti, Maurizio and Giustetto, Maurizio},
  title = {Clinical Validation of α‐Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {2},
  doi = {10.1111/ene.70508}
}
Kostenlos starten →